<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04989062</url>
  </required_header>
  <id_info>
    <org_study_id>201901889A3</org_study_id>
    <nct_id>NCT04989062</nct_id>
  </id_info>
  <brief_title>Predicting Obesity Consequences Using Body Measure and Urine Metabolomics</brief_title>
  <official_title>Predicting Obesity Consequences Using Body Measure and Urine Metabolomics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Science and Technology, Taiwan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective observational study which will recruit up to 1200 participants over a&#xD;
      two-year period to investigate whether non-invasive methods such as bioelectrical impedance&#xD;
      analysis parameters and urine metabolic profile are predictors for pediatric non-alcoholic&#xD;
      liver disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obesity is associated with non-alcoholic fatty liver in children. Currently, body mass index&#xD;
      is used for stratification risk for non-alcoholic fatty liver disease in children. However,&#xD;
      body mass index represents the adjusted weight status for height and may not be a perfect&#xD;
      surrogate for body fatness. This study assumes that a combination of body measures including&#xD;
      parameters of bioelectrical impedance analysis and hand grip strength may better represented&#xD;
      body fatness and healthy status than body mass index. Moreover, non-alcoholic fatty liver&#xD;
      disease is strongly associated with the metabolic syndrome and non-invasive urine metabolic&#xD;
      profile may be used to predict the disease status. The aim of this study will be to develop&#xD;
      non-invasive methods using body measures and urine metabolic profile to predict pediatric&#xD;
      fatty liver disease.&#xD;
&#xD;
      This study will recruit 1200 apparently healthy children at Year 1 to Year 6 in the primary&#xD;
      schools in Taiwan within a two-year period. A series of tests including body measures,&#xD;
      bioelectrical impedance analysis, hand grip strength and urine metabolomics by nuclear&#xD;
      magnetic resonance will be performed in each participant. These data will be used as features&#xD;
      to predict the results of Fibroscan test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Anticipated">July 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation between bioelectrical impedance analysis parameters and the degree of fatty liver</measure>
    <time_frame>24 months</time_frame>
    <description>Correlation body composition parameters by bioelectrical impedance analysis and controlled attenuation parameter by Fibroscan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation between urine metabolites and the degree of fatty liver</measure>
    <time_frame>24 months</time_frame>
    <description>Correlation between urine metabolites by nuclear magnetic resonance and controlled attenuation value parameter by Fibroscan</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Non-Alcoholic Fatty Liver Disease</condition>
  <condition>Body Composition</condition>
  <condition>Electric Impedance</condition>
  <arm_group>
    <arm_group_label>Healthy children</arm_group_label>
    <description>Apparently healthy children at Year 1 to Year 6 in the primary school in Taiwan. Exclusion criteria are children with metal implant or splint, pacemaker implantation, limb defect or injury and pregnant.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Fibroscan</intervention_name>
    <description>Controlled attenuation parameter and liver stiffness measurement are measured.</description>
    <arm_group_label>Healthy children</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Bioelectrical impedance analysis</intervention_name>
    <description>Body composition measures including fat mass, fat-free mass, percentage body fat in total body and body segments are obtained.</description>
    <arm_group_label>Healthy children</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Urine unclear magnetic resonance metabolomics</intervention_name>
    <description>Metabolites in the urine are estimated by 600 MHz nuclear magnetic resonance.</description>
    <arm_group_label>Healthy children</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Hand grip strength</intervention_name>
    <description>Hand grip strength in both hands is measured by hand-held dynamometer.</description>
    <arm_group_label>Healthy children</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Urine samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants in the Year 1 to Year 6 of primary school (aged 6-13 years) without liver&#xD;
        disease will be recruited for body measure, urine sampling and Fibroscan test.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Apparently healthy male or female children&#xD;
&#xD;
          -  Students in Year 1 to Year 6 of primary schools&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unknown liver disease&#xD;
&#xD;
          -  Metal implant or splint&#xD;
&#xD;
          -  Pacemaker implantation&#xD;
&#xD;
          -  Limb defect or injury&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>13 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Li-Wen Lee, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chang Gung Memorial Hospital, Chiayi, Taiwan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Li-Wen Lee, MD, PhD</last_name>
    <phone>+886 5 3621 000</phone>
    <phone_ext>2382</phone_ext>
    <email>m4572@cgmh.org.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chang Gung Memorial Hospital</name>
      <address>
        <city>Chiayi City</city>
        <zip>61363</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Li-Wen Lee, MD, PhD</last_name>
      <phone>+886 5 3621 000</phone>
      <phone_ext>2382</phone_ext>
      <email>m4572@cgmh.org.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 11, 2021</study_first_submitted>
  <study_first_submitted_qc>July 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 4, 2021</study_first_posted>
  <last_update_submitted>July 24, 2021</last_update_submitted>
  <last_update_submitted_qc>July 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chang Gung Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Li-Wen Lee</investigator_full_name>
    <investigator_title>Consultant Radiologist</investigator_title>
  </responsible_party>
  <keyword>Non-Alcoholic Fatty Liver Disease</keyword>
  <keyword>Body Composition</keyword>
  <keyword>Electric Impedance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

